Tumor-feeding artery diameter reduction is associated with improved short-term effect of hepatic arterial infusion chemotherapy plus lenvatinib treatment.

MLA

Wu, De-Di, et al. “Tumor-Feeding Artery Diameter Reduction Is Associated with Improved Short-Term Effect of Hepatic Arterial Infusion Chemotherapy plus Lenvatinib Treatment.” World Journal of Gastroenterology, vol. 28, no. 26, July 2022, pp. 3232–42. EBSCOhost, https://doi.org/10.3748/wjg.v28.i26.3232.

APA

Wu, D.-D., He, X.-F., Tian, C., Peng, P., Chen, C.-L., Liu, X.-H., & Pang, H.-J. (2022). Tumor-feeding artery diameter reduction is associated with improved short-term effect of hepatic arterial infusion chemotherapy plus lenvatinib treatment. World Journal of Gastroenterology, 28(26), 3232–3242. https://doi.org/10.3748/wjg.v28.i26.3232

Chicago

Wu, De-Di, Xiao-Feng He, Chen Tian, Peng Peng, Chuan-Li Chen, Xue-Han Liu, and Hua-Jin Pang. 2022. “Tumor-Feeding Artery Diameter Reduction Is Associated with Improved Short-Term Effect of Hepatic Arterial Infusion Chemotherapy plus Lenvatinib Treatment.” World Journal of Gastroenterology 28 (26): 3232–42. doi:10.3748/wjg.v28.i26.3232.